Ind-Swift Laboratories Limited (INDSWFTLAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.015x

Based on the latest financial reports, Ind-Swift Laboratories Limited (INDSWFTLAB) has a cash flow conversion efficiency ratio of -0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-202.50 Million ≈ $-2.19 Million USD) by net assets (Rs13.07 Billion ≈ $141.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INDSWFTLAB days of operational coverage to measure how many days the company can operate on defensive assets alone.

Ind-Swift Laboratories Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Ind-Swift Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ind-Swift Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ind-Swift Laboratories Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Immunic Inc NASDAQ:IMUX	2.889x
Acme United Corporation NYSE MKT:ACU	-0.019x
Ilyang Pharm KO:007570	0.009x
Oando PLC JSE:OAO	-0.158x
Pinago Utama Tbk Pt JK:PNGO	0.094x
Prospect Resources Ltd AU:PSC	-0.090x
MAX Automation SE XETRA:MXHN	0.111x
Quanterix Corp NASDAQ:QTRX	-0.131x

Annual Cash Flow Conversion Efficiency for Ind-Swift Laboratories Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Ind-Swift Laboratories Limited worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs11.73 Billion ≈ $126.85 Million	Rs-254.74 Million ≈ $-2.75 Million	-0.022x	+89.19%
2024-03-31	Rs8.12 Billion ≈ $87.82 Million	Rs-1.63 Billion ≈ $-17.64 Million	-0.201x	-170.38%
2023-03-31	Rs6.82 Billion ≈ $73.75 Million	Rs1.95 Billion ≈ $21.05 Million	0.285x	+14.11%
2022-03-31	Rs6.01 Billion ≈ $64.98 Million	Rs1.50 Billion ≈ $16.25 Million	0.250x	+11.83%
2021-03-31	Rs6.03 Billion ≈ $65.26 Million	Rs1.35 Billion ≈ $14.59 Million	0.224x	+14.40%
2020-03-31	Rs6.41 Billion ≈ $69.28 Million	Rs1.25 Billion ≈ $13.54 Million	0.195x	+278.44%
2019-03-31	Rs5.88 Billion ≈ $63.57 Million	Rs-644.00 Million ≈ $-6.96 Million	-0.110x	-182.93%
2018-03-31	Rs5.53 Billion ≈ $59.83 Million	Rs730.90 Million ≈ $7.90 Million	0.132x	-26.55%
2017-03-31	Rs5.31 Billion ≈ $57.46 Million	Rs955.66 Million ≈ $10.34 Million	0.180x	+17.17%
2016-03-31	Rs5.17 Billion ≈ $55.96 Million	Rs794.30 Million ≈ $8.59 Million	0.154x	-7.25%
2015-03-31	Rs5.95 Billion ≈ $64.30 Million	Rs983.98 Million ≈ $10.64 Million	0.166x	+83.17%
2014-03-31	Rs7.25 Billion ≈ $78.43 Million	Rs655.29 Million ≈ $7.09 Million	0.090x	+265.47%
2013-03-31	Rs8.53 Billion ≈ $92.30 Million	Rs-466.03 Million ≈ $-5.04 Million	-0.055x	-161.11%
2012-03-31	Rs8.12 Billion ≈ $87.78 Million	Rs725.24 Million ≈ $7.84 Million	0.089x	+193.19%
2011-03-31	Rs5.84 Billion ≈ $63.10 Million	Rs177.83 Million ≈ $1.92 Million	0.030x	-69.08%
2010-03-31	Rs4.48 Billion ≈ $48.48 Million	Rs441.84 Million ≈ $4.78 Million	0.099x	-64.25%
2009-03-31	Rs3.63 Billion ≈ $39.27 Million	Rs1.00 Billion ≈ $10.83 Million	0.276x	+61.91%
2008-03-31	Rs3.33 Billion ≈ $36.06 Million	Rs567.77 Million ≈ $6.14 Million	0.170x	+17.18%
2007-03-31	Rs3.11 Billion ≈ $33.68 Million	Rs452.62 Million ≈ $4.89 Million	0.145x	+137.58%
2006-03-31	Rs1.92 Billion ≈ $20.80 Million	Rs117.63 Million ≈ $1.27 Million	0.061x	--

About Ind-Swift Laboratories Limited

NSE:INDSWFTLAB India Drug Manufacturers - Specialty & Generic

Market Cap

$158.41 Million

Rs14.65 Billion INR

Market Cap Rank

#17535 Global

#914 in India

Share Price

Rs168.68

Change (1 day)

+3.82%

52-Week Range

Rs88.15 - Rs168.68

All Time High

Rs176.72